Where and by whom should gastric cancer HER2/neu status be assessed? Lessons from breast cancer

Where and by whom should gastric cancer HER2/neu status be assessed? Lessons from breast cancer

Archives of Pathology and Laboratory Medicine

Saved in:

書目詳細資料
Main Authors:	Salto-Tellez, M., Yau, E.X., Yan, B., Fox, S.B.
其他作者:	CANCER SCIENCE INSTITUTE OF SINGAPORE
格式:	Editorial
出版:	2014
在線閱讀:	http://scholarbank.nus.edu.sg/handle/10635/108627
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

A study of HER2 gene amplification and protein expression in gastric cancer
由: Yan, B., et al.
出版: (2014)

Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer
由: Zhang, D.-H., et al.
出版: (2012)

Proteomics of breast cancer: enhanced expression of CK19 in HER-2/neu-positive tumours.
由: Tai, L.K., et al.
出版: (2016)

Detection of HER2/neu gene amplification in archival paraffin-embedded breast cancer tissues by fluorescence in situ hybridization
由: Selvarajan, S., et al.
出版: (2015)

Dual-colour HER2/Chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples
由: Yan, B., et al.
出版: (2014)

CC3/TIP30 expression was strongly associated with HER-2/NEU status in breast cancer.
由: Lee, L.W., et al.
出版: (2012)

Phosphorylation of Ser78of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer
由: Zhang, D., et al.
出版: (2012)

Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis
由: Wong, L.L., et al.
出版: (2012)

Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer
由: Zhang, D., et al.
出版: (2012)

Heregulin-Enhanced Tyrosine Phosphorylation in Breast Cancer Cells: Role of PP2A in HER-2/neu Oncogenic Signalling
由: WONG LEE LEE
出版: (2011)

Cell surface her2/neu oncoprotein expression in breast ductal carcinoma
由: Imam Susilo, NIDN. 0010086503
出版: (2008)

Proteomic characterization of differentially expressed proteins in breast cancer: Expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER-2/neu status
由: Zhang, D., et al.
出版: (2012)

Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression
由: Anthony Nguyen, et al.
出版: (2018)

The significance of HER-2/neu/c-erbB-2 gene amplification in benign and malignant breast disease
由: Kasama Supanaranond, et al.
出版: (2018)

Clinical and therapeutic relevance of PIM1 kinase in gastric cancer
由: Yan, B., et al.
出版: (2014)

HER2 expression in breast cancer with nonamplified HER2 and gains of chromosome 17 centromere
由: Ravat Panvichian, et al.
出版: (2018)

Brain metastases in Asian HER2-positive breast cancer patients: Anti-HER2 treatments and their impact on survival
由: Yap, Y.S., et al.
出版: (2014)

Case Study on 'Whom Should He Leave the Business To?'
由: FOCK, Siew Tong
出版: (2001)

Locoregional recurrence in patients with HER2 positive breast cancer
由: Janaina Brollo, et al.
出版: (2018)

Proteomics analysis of Her-2/neu-linked protein profiles in tumor microenvironment
由: TAI LEE KIAN
出版: (2010)

Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference
由: Tan, W.B., et al.
出版: (2014)

Whom should I talk to?: And how that can affect my work
由: DATTA, Subhajit
出版: (2021)

Prognosticating gastric cancer
由: Yeoh, K.G., et al.
出版: (2011)

Preclinical characteristics of the irreversible pan-HER kinase inhibitor neratinib compared with lapatinib : implications for the treatment of HER2-positive and HER2-mutated breast cancer
由: Collins, Denis M., et al.
出版: (2020)

Preclinical characteristics of the irreversible pan- her kinase inhibitor neratinib compared with lapatinib: Implications for the treatment of HER2- positive and HER2-mutated breast cancer
由: Collins, D.M., et al.
出版: (2021)

Breast cancer subtypes identified by the ER, PR and HER-2 status in thai women
由: Suebwong Chuthapisith, et al.
出版: (2018)

Bioactivity of Black Cumin Oil on the Senescence of Her-2-Overexpressing Breast Cancer Cells
由: Ahlina, Faradiba Nur, et al.
出版: (2022)

IT Orientation, CIO reporting structure and Firm Performance: To Whom Should the CIO Report?
由: BANKER, Rajiv, et al.
出版: (2004)

Where should water come from?
由: RANDLE, Sayd
出版: (2022)

BREAst screening Tailored for HEr (BREATHE)-A study protocol on personalised risk-based breast cancer screening programme
由: Liu, Jenny, et al.
出版: (2022)

Anti‐proliferative effects of pentagamaboronon‐0‐sorbitol on HER2‐overexpressing breast cancer cells
由: Qodria, Lailatul, et al.
出版: (2022)

Neural additive models for predicting her2 status in breast cancer from immunohistochemical images
由: Surayuth Pintawong
出版: (2024)

Where should I focus on? : Identifying where to focus for question generation
由: Low, Brendon Wei Jie
出版: (2021)

Gene-Environment Interactions: Where are we and where Should we be Going?
由: Ordovas, J.M., et al.
出版: (2016)

Hubungan Ekspresi Her-2/Neu, Skor Gleason dan Metastasis Tulang pada Adenokarsinoma Prostat
由: Nina Mardiana, 091070854, et al.
出版: (2013)

HER2/neu expression in patients with primary uterine endometrial carcinomas in Batangas Medical Center, Philippines
由: Bacong, D.A. R., et al.
出版: (2021)

Towards whom should indoor environmental quality control be sympathetic : asthmatics or non-asthmatics?
由: Tham, Kwok Wai, et al.
出版: (2014)

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
由: Anchalee Tantiwetrueangdet, et al.
出版: (2019)

Endoscopic Screening for Gastric Cancer
由: Dan, Y.Y., et al.
出版: (2011)

Cultural Geography: By Whom, for Whom?
由: Kong, Lily
出版: (2004)